Charles River Laboratories | CRL - Sales Revenues


Charles River Laboratories reported $995.8M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
Align Technology USD 1.06B 20M Jun/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cigna USD 71.7B 3.18B Jun/2026
Concord Medical Services Hldg CNY 259.9M 59.28M Dec/2025
CVS Health USD 100.4B 5.3B Mar/2026
Danaher USD 6.3B 350M Jun/2026
Dentsply International USD 880M 81M Mar/2026
Elevance Health USD 49.8B 300M Jun/2026
Humana USD 40.89B 1.24B Jun/2026
Illumina USD 1.16B 70M Jun/2026
Incyte USD 1.67B 400M Jun/2026
Intrexon USD 717K 511K Jun/2024
IQVIA Holdings USD 4.37B 220M Jun/2026
Laboratory Of America USD 3.73B 190M Jun/2026
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Lonza CHF 3.58B 63M Jun/2025
McKesson USD 92.3B 13.86B Mar/2026
Merck EUR 5.13B 120M Mar/2026
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Novartis USD 14.41B 1.3B Jun/2026
Pfizer USD 15.03B 530M Jun/2026
Quest Diagnostics USD 3.04B 140M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
United Therapeutics USD 781.5M 8.7M Mar/2026
UnitedHealth USD 112B 300M Jun/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 1.64B 370M Jun/2026
West Pharmaceutical Services USD 872.3M 27.4M Jun/2026